Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.
[read the full story...]
Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.
[read the full story...]
Ben Perry publishes his debut blog on a recent systematic review of impaired glucose homeostasis in first-episode schizophrenia.
[read the full story...]